Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Exploring the Properties and Applications of ACP-105 with CAS Number 20899821-23-9

Aug . 11, 2024 17:58 Back to list

Exploring the Properties and Applications of ACP-105 with CAS Number 20899821-23-9



ACP-105 A Comprehensive Overview of CAS 20899821-23-9


ACP-105, identified by its CAS number 20899821-23-9, is a non-steroidal selective androgen receptor modulator (SARM) that has garnered attention in the fields of medicinal chemistry and sports science. This compound presents a novel approach to enhancing muscle growth and strength without the adverse effects commonly associated with anabolic steroids. As researchers continue to unravel its properties and potential applications, understanding ACP-105's mechanisms, benefits, and safety profile becomes crucial.


Mechanism of Action

ACP-105 functions by selectively binding to androgen receptors (AR) in muscle and bone tissues. This selective binding distinguishes it from traditional anabolic steroids, which can affect various tissues, leading to a range of side effects such as liver damage, hormonal imbalances, and other health complications. By targeting specific ARs, ACP-105 promotes anabolic activity primarily in skeletal muscle and enhances bone density, making it a promising candidate for treating conditions such as muscle wasting, osteoporosis, and other age-related degenerative diseases.


Benefits of ACP-105


One of the primary advantages of ACP-105 is its ability to stimulate muscle growth and improve physical performance. Studies indicate that it can significantly increase lean muscle mass and strength, making it attractive not only to individuals suffering from muscle degenerative diseases but also to athletes and bodybuilders seeking performance enhancement without the risks associated with traditional steroids. Moreover, ACP-105 demonstrates a favorable safety profile, with a lower incidence of common side effects like gynecomastia and water retention, which are often reported with steroid use.


cas 899821-23-9 acp-105

cas 899821-23-9 acp-105

In addition to its anabolic effects, ACP-105 has been noted for its potential cognitive benefits. There is emerging evidence suggesting that this molecule may possess neuroprotective properties, potentially aiding in the prevention of cognitive decline associated with aging or neurodegenerative diseases. This multifaceted profile makes ACP-105 a compound of significant interest in both the medical and athletic communities.


Research and Development


Although ACP-105 is still under research, preliminary studies have shown promising results. In animal models, it has demonstrated effective muscle-building capabilities, with substantial increases in muscle mass and strength observed. However, further clinical trials in humans are necessary to fully establish its efficacy and safety profile.


The regulatory landscape surrounding SARMs, including ACP-105, is evolving. Many sports organizations have banned the use of SARMs due to their performance-enhancing effects, leading to a cautious approach among athletes. While the substance may offer benefits, the ethical implications and the potential for misuse in competitive sports cannot be overlooked.


Conclusion


In conclusion, ACP-105 (CAS 20899821-23-9) represents a significant advancement in the search for effective muscle growth solutions. With its selective action on androgen receptors and a growing body of research indicating its potential benefits, ACP-105 is positioned as a promising compound for therapeutic applications and athletic performance enhancement. However, as with any pharmacological agent, careful consideration must be given to its use, particularly in sports contexts, where the line between legitimate medical use and performance enhancement can become blurred. Ongoing research will be crucial to unlock the full potential of ACP-105 and ensure its safe application in various domains.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish